These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2416441)

  • 1. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour markers in urology: aids in cancer diagnosis and management.
    Wahren B
    Urol Res; 1979 Jun; 7(2):57-67. PubMed ID: 89748
    [No Abstract]   [Full Text] [Related]  

  • 5. Placental proteins as tumor markers.
    Braunstein GD
    Immunol Ser; 1990; 53():673-701. PubMed ID: 1713070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor markers].
    Cappelaere P
    Rev Prat; 1988 Jun; 38(17):1058-63. PubMed ID: 2457249
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor markers in advanced nonseminomatous testicular cancer.
    Bosl GJ; Lange PH; Nochomovitz LE; Goldmann A; Fraley EE; Rosai J; Johnson K; Kennedy BJ
    Cancer; 1981 Feb; 47(3):572-6. PubMed ID: 6164464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers in gynecologic malignancies].
    Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
    Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of germ cell and trophoblastic neoplasms.
    Niehans GA; Manivel JC; Copland GT; Scheithauer BW; Wick MR
    Cancer; 1988 Sep; 62(6):1113-23. PubMed ID: 2457424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
    Tottori K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of serum tumor markers in cancer diagnosis and management.
    Bates SE; Longo DL
    Semin Oncol; 1987 Jun; 14(2):102-38. PubMed ID: 2438773
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor-associated antigens in polyps and carcinoma of the human large bowel.
    Skinner JM; Whitehead R
    Cancer; 1981 Mar; 47(6):1241-5. PubMed ID: 6164469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preneoplasia and neoplasia of the bronchus, esophagus, and colon: the use of markers in determining phenotypes and classification.
    Trump BF; McDowell EM; Shamsuddin AK; Phelps PC; Purnell DM; Wilson TS; Banks-Schlegel SP; Kurland CL; Harris CC
    Monogr Pathol; 1985; (26):101-39. PubMed ID: 2414648
    [No Abstract]   [Full Text] [Related]  

  • 14. Value of five tumor markers (AFP, CEA, hCG, hPL and SP1) in diagnosis and staging of testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Kamińska JA; Gadek A
    Oncology; 1981; 38(4):222-9. PubMed ID: 6165945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sense and nonsense of tumor markers in practice].
    Joss R; Cerny T
    Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
    Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Placental and embryonal proteins as antigens in the immunodiagnosis of malignant tumors].
    Tatarinov IuS
    Vestn Akad Med Nauk SSSR; 1977; (10):90-3. PubMed ID: 72463
    [No Abstract]   [Full Text] [Related]  

  • 18. Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
    Fowler JE; Sesterhenn I; Stutzman RE; Mostofi FK
    Urology; 1983 Dec; 22(6):649-54. PubMed ID: 6196899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers in the plasma and tumors of patients with gynecologic malignancies.
    van Nagell JR; Donaldson ES; Hanson MB; Gay EC; Pavlik EJ
    Cancer; 1981 Jul; 48(2 Suppl):495-503. PubMed ID: 6168368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.